Double Blind Random Experimental Testing

Google+ Pinterest LinkedIn Tumblr +

Trials of prospective medication, especially critical vaccines need to be as objective as humanly possible. This is because mental factors can knock through to physical responses, and influence results. We explore double blind random experimental testing in this post. That’s because vaccine trials are large-scale experiments to test the assumption a vaccine is effective, or otherwise.

What is Double Blind Random Experimental Testing?

Randomized clinical trials are experiments where neither the administrator, nor the subject knows which shot is being used. It could be the real thing, a different medication, or a neutral placebo. Scientists call this method double blind random experimental testing, because neither party has ‘sight’ of the truth.

Of course, each shot will have a random serial number, and that record will appear in patient and test records. This method minimizes the human factor, and improves the statistical reliability of a clinical trial. It also also helps ensure subject expectations, and observer  / administrator  influence should not play a significant role.

‘Un-Blinding’ As the Experimental Trial Proceeds

Other resources, often computers are ‘sighted’ and able to interpret the random serial numbers. However, this information is out of reach of administrators and subjects, until the experimental trial is complete.  Thereafter, the information may be provided to individual subjects, as a polite courtesy.

There are two common variations of double blind testing. The first is single-blind, where only subjects are in the dark. While triple blind trials also keep the data from third parties, such as monitoring committees.

Random, double blind placebo controls are the ‘gold standard’ of epidemiological studies. This is according to National Center for Biotechnology Research, per the link at the end of this post. Vaccines trialed outside this method may turn out flawed, and the benefits questionable.

Related

Monoclonal Antibodies Trialing in the UK

AstraZeneca Trials Are Continuing in UK

Preview Image: Mahatma Gandhi’s Three Monkeys

National Center for Biotechnology Assessment

Share.

About Author

I have been writing about batteries and energy storage for more than ten years, and have published over 4,000 articles on this website. During that time, I have researched developments across lead-acid, lithium-ion, sodium-ion, flow batteries, and emerging energy-storage technologies. My goal is to explain complex battery concepts in clear, practical language that anyone can understand. My writing career began unexpectedly after leaving the corporate world. What started as a search for a new direction gradually became a fascination with batteries, renewable energy, and the science that powers modern life. Writing may not have made me wealthy, but it has given me the opportunity to explore an industry that continues to evolve in remarkable ways.

Leave A Reply